| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/07/2001 | EP1079807A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract |
| 03/07/2001 | EP1079806A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear |
| 03/07/2001 | EP1079802A2 Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulations into mucosal cavities |
| 03/07/2001 | EP0486526B2 Tumour necrosis factor binding ligands |
| 03/07/2001 | CN1286726A Histamine and serotonin binding molecules |
| 03/07/2001 | CN1286258A Purine L-nucleoside, analogs and use thereof |
| 03/06/2001 | US6197939 Polypeptide regulator; for use as a diagnostic tool in detection of tumors |
| 03/06/2001 | US6197934 Compound delivery using rapidly dissolving collagen film |
| 03/06/2001 | US6197931 Human marco scavenger receptor |
| 03/06/2001 | US6197930 Polypeptide for use in organ preservation, cryopreservation, for surgical pretreatment to prevent injury due to inflammation; antiischemic agents |
| 03/06/2001 | US6197832 Composition for reducing serum cholesterol levels |
| 03/06/2001 | US6197827 Nicotine receptor antagonists and either an anti-depressant or an anti-anxiety drug, mecamylamine and bupropion |
| 03/06/2001 | US6197823 Pain reliever and method of use |
| 03/06/2001 | US6197801 Injectable pharmaceutical composition for treatment and reversal of erectile dysfunction |
| 03/06/2001 | US6197787 Pharmaceutical formulations containing poorly soluble drug substances |
| 03/06/2001 | US6197786 Anticholesterol agents |
| 03/06/2001 | US6197782 Therapy for sexual disorders |
| 03/06/2001 | US6197780 Administering an endothelin anatgonist |
| 03/06/2001 | US6197778 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 03/06/2001 | US6197767 Arglabin compounds and therapeutic uses thereof |
| 03/06/2001 | US6197764 Clozapine compositions and uses thereof |
| 03/06/2001 | US6197762 Nitrosated and nitrosylated steroids compositions, and methods for treating respiratory disorders |
| 03/06/2001 | US6197745 Methods for producing nitrosated hemoglobins and therapeutic uses therefor |
| 03/06/2001 | US6197743 Concurrent administering induction agent and viricides |
| 03/06/2001 | US6197584 Antisense modulation of CD40 expression |
| 03/06/2001 | US6197581 Human adenylate cyclase and use therefor |
| 03/06/2001 | US6197580 Transcriptional regulation of the human β3-adrenergic receptor gene |
| 03/06/2001 | US6197530 GPR10 as a target for identifying weight modulating compounds |
| 03/06/2001 | US6197524 Methods for detecting, identifying, isolating, and selectively labelling and targeting TH1 lymphocyte by means of the LAG-3 protein |
| 03/06/2001 | US6197511 Amino acid sequence; diagosis and treatment of cancer and skin disorders; anticarcinogenic agents; recombinant production; hybridization probes |
| 03/06/2001 | US6197505 Nucleic acid derived from human gene which encodes angiotensin converting enzyme and which is polymorphic at one or several positions; screening for predisposition; assessing responsiveness of individual to treatment regimen |
| 03/06/2001 | US6197351 Treatment of endometrial mucosa of uterus tissues |
| 03/06/2001 | US6197329 Anti-nausea compositions and methods |
| 03/06/2001 | US6197327 Device and method for treatment of dysmenorrhea |
| 03/06/2001 | US6197324 Implanting local anesthetic into myocardial tissue |
| 03/06/2001 | US6197309 Mixture containing vitamins, minerals, plant extracts and amino acids |
| 03/06/2001 | US6197306 Herbal composition for the treatment of chronic obstructive pulmonary disease, bronchitis and respiratory disorders and a process for preparing the same |
| 03/06/2001 | US6197300 ftsZ |
| 03/06/2001 | US6197069 Adrenomedullin receptor polynucleotides |
| 03/01/2001 | WO2001014886A2 Inhibitors of binding between proteins and macromolecular ligands |
| 03/01/2001 | WO2001014584A2 Methods of identifying anti-viral agents |
| 03/01/2001 | WO2001014581A2 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 03/01/2001 | WO2001014557A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | WO2001014556A1 Novel b7-4 molecules and uses therefor |
| 03/01/2001 | WO2001014551A1 NOVEL bHLH TYPE TRANSCRIPTION FACTOR GENE DEC2 |
| 03/01/2001 | WO2001014549A1 Gas1 polypeptides |
| 03/01/2001 | WO2001014548A2 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | WO2001014542A1 A transmembrane trap for isolating membrane bound proteins |
| 03/01/2001 | WO2001014535A2 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β1,3-N-ACETYLGALACTOSAMINE-α-R/(GlcNAc to GalNAc) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 03/01/2001 | WO2001014414A2 Human abc2 transporter and uses thereof |
| 03/01/2001 | WO2001014368A1 Compounds, compositions and methods for treating influenza |
| 03/01/2001 | WO2001014365A1 COMPOSITIONS AND METHODS FOR MODULATING APOPTOSIS IN CELLS OVER-EXPRESSING bcl-2 FAMILY MEMBER PROTEINS |
| 03/01/2001 | WO2001013967A1 Solid wound healing formulations containing fibronectin |
| 03/01/2001 | WO2001013957A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | WO2001013956A2 Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications |
| 03/01/2001 | WO2001013954A1 Method of treating body insect infestation |
| 03/01/2001 | WO2001013953A2 Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist |
| 03/01/2001 | WO2001013952A1 Preventives/remedies for heart failure |
| 03/01/2001 | WO2001013950A1 Percutaneous absorption agents |
| 03/01/2001 | WO2001013949A2 Medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases |
| 03/01/2001 | WO2001013935A2 Modulation of the blood-brain barrier transporter for leptin |
| 03/01/2001 | WO2001013933A2 Agents for the enhanced oxygen delivery in mammals |
| 03/01/2001 | WO2001013932A2 Stimulation of sperm function |
| 03/01/2001 | WO2001013927A2 Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof |
| 03/01/2001 | WO2001013923A1 Malaria gpi anchors as vaccines anti-parasitic drugs and for use in diagnostics |
| 03/01/2001 | WO2001013913A1 Compositions containing esters for treating parasitic infestations of organisms |
| 03/01/2001 | WO2001013909A2 Compositions and methods for treating opiate intolerance |
| 03/01/2001 | WO2001013908A2 Tissue volume reduction |
| 03/01/2001 | WO2001013907A2 Pharmaceutical combination for the treatment of viral infections containing a calcium channel blocker and a quinoline |
| 03/01/2001 | WO2001013905A2 Methods for the treatment of mental and vascular disorders |
| 03/01/2001 | WO2001013904A2 Composition comprising a tramadol material and an anticonvulsant drug |
| 03/01/2001 | WO2001013903A2 Treatment of restless leg syndrome with a combination of clonidine and opioid |
| 03/01/2001 | WO2001013900A2 Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds |
| 03/01/2001 | WO2001013897A1 Oral liquid compositions |
| 03/01/2001 | WO2001013892A2 Large porous particles by spray-drying |
| 03/01/2001 | WO2001013887A2 Phospholipin gel |
| 03/01/2001 | WO2001013865A1 Pharmaceutical compositions and methods for reducing the appearance of cellulite |
| 03/01/2001 | WO2001013733A1 Fat or oil composition |
| 03/01/2001 | WO2001000181A3 Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
| 03/01/2001 | WO2000075365A3 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION |
| 03/01/2001 | WO2000073449B1 Dna encoding snorf33 receptor |
| 03/01/2001 | WO2000073445A3 Interleukin-1-receptor associated kinase-3 (irak3) |
| 03/01/2001 | WO2000072885A9 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 03/01/2001 | WO2000071752A3 Assay for the detection of paclitaxel resistant cells in human tumors |
| 03/01/2001 | WO2000071146A3 Glutathione reductase for therapy and prophylaxis of aids |
| 03/01/2001 | WO2000071109A3 Pharmaceutical compositions comprising s-(+) -desmethylselegiline for the treatment of withdrawal |
| 03/01/2001 | WO2000064422A3 Novel treatment of neurotraumatic conditions with raf inhibitor |
| 03/01/2001 | WO2000056361A3 Vaccine composition |
| 03/01/2001 | WO2000023060A8 Method of treating immunological disorders mediated by t-lymphocytes |
| 03/01/2001 | WO2000023037A8 Two chamber cartridge for atomizers |
| 03/01/2001 | WO1999043314A9 Farnesyl-protein transferase inhibitors |
| 03/01/2001 | DE19941024A1 Wirkstoffpräparat für tierärztliche Applikation und Verfahren zu seiner Herstellung Drug product for veterinary application and process for its production |
| 03/01/2001 | DE10036854A1 Neue kristalline Form von 6-Hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophenhydrochlorid New crystalline form of 6-hydroxy-3- (4- [2- (piperidin-1-yl) ethoxy] phenoxy) -2- (4-methoxyphenyl) benzo [b] thiophene hydrochloride |
| 03/01/2001 | CA2715683A1 Synergistic combination |
| 03/01/2001 | CA2383559A1 Inhibitors of binding between proteins and macromolecular ligands |
| 03/01/2001 | CA2383491A1 Large porous particles by spray-drying |
| 03/01/2001 | CA2383456A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | CA2383252A1 Treatment of cardiovascular related pathologies |
| 03/01/2001 | CA2383063A1 Human abc2 transporter and uses thereof |
| 03/01/2001 | CA2382817A1 Use of fibrin or fibrinogen for reducing lung tissue volume |